Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_assertion type Assertion NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_head.
- NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_provenance.
- NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_assertion evidence source_evidence_literature NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_provenance.
- NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_assertion SIO_000772 20512928 NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_provenance.
- NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_assertion wasDerivedFrom befree-20140225 NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_provenance.
- NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_assertion wasGeneratedBy ECO_0000203 NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_provenance.